对美国感染病学会（IDSA）2016年发布的曲霉病诊断和管理实践指南的评论。
Comments on practice guidelines for the diagnosis and management of aspergillosis made by the IDSA in 2016.
作者信息
Alarcón-Manoja E, Cardozo-Espinola C, Puerta-Alcalde P, García-Vidal C
机构信息
Pedro Puerta-Alcalde, Department of Infectious Diseases, Hospital Clínic. Villarroel 170, 08036, Barcelona, Spain.
出版信息
Rev Esp Quimioter. 2017 Sep;30 Suppl 1:26-29.
We sought to review the most important updates in the treatment of aspergillosis after the publication of the clinical practice guidelines for the diagnosis and management of invasive aspergillosis (IA) by the Infectious Diseases Society of America. Our aim is to discuss some of the key aspects concerning the following topics: early initiation of antifungal therapy, antifungal agent of choice, follow-up of patients with IA, and breakthrough aspergillosis.
在美国传染病学会发布侵袭性曲霉病（IA）诊断和管理临床实践指南之后，我们试图回顾曲霉病治疗方面最重要的更新内容。我们的目的是讨论以下主题的一些关键方面：抗真菌治疗的早期启动、首选抗真菌药物、IA患者的随访以及突破性曲霉病。
Zotero 插件